Virginia Cancer Specialists Enrolls First Patient in Phase 1/2 Clinical Trial of BION-1301-Novel Anti-APRIL Antibody, Treatment of Multiple Myeloma

Virginia Cancer Specialists, the largest private cancer practice in Northern Virginia, was recognized in 2024 and 2025 as the #1 physician practice in Virginia with the most Castle Connolly top doctors in cancer care and across all medical specialties. It features a world-class treatment team fighting cancer and diseases of the blood, offering access to the most current treatment protocols, clinical trials, and comprehensive care. Its fully staffed, comprehensive clinical research program also includes a dedicated research facility for Phase I clinical trials—the Virginia Cancer Specialists Research Institute, the largest of its kind in the Mid-Atlantic region. The practice offers medical oncology, radiation oncology, musculoskeletal tumor surgery, breast surgery, thoracic surgery, genetic counseling, palliative care, oncology nurse navigators, oncology infusion nurses, oncology pharmacists, social workers, dietitians, and laboratory technicians. Virginia Cancer Specialists is part of The US Oncology Network. This collaboration unites the practice with more than 1,400 independent physicians and research and data from thousands of cancer patients in clinical trials across the country. Virginia Cancer Specialists also participates in clinical trials through US Oncology Research, which has played a role in more than 100 FDA-approved cancer therapies. For more information, visit USOncology.com. For more information about Virginia Cancer Specialists, visit: VirginiaCancerSpecialists.com

The Network is supported by McKesson Corporation, a global leader in healthcare solutions.

SOURCE Virginia Cancer Specialist